P-164Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival. (20th June 2018) - Pacheco-Barcia, V; France, T; Zogopoulos, G; Bouganim, N; Donnay, O; Alcindor, T; Solís, R Mondéjar; Guo, K; Martin, E; Colomer, R; Asselah, J